title: Complete response to erlotinib treatment in brain metastases from recurrent NSCLC.
authors.forename: C S L
authors.initials: CS
authors.lastname: Lai
authors.forename: C
authors.initials: C
authors.lastname: Boshoff
authors.forename: M
authors.initials: M
authors.lastname: Falzon
authors.forename: S M
authors.initials: SM
authors.lastname: Lee
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000556:secondary*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011799:Quinazolines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride